Navigation Links
Kessler researchers find aerobic exercise benefits memory in persons with multiple sclerosis
Date:11/1/2013

West Orange, NJ. November 1, 2013. A research study headed by Victoria Leavitt, Ph.D. and James Sumowski, Ph.D., of Kessler Foundation, provides the first evidence for beneficial effects of aerobic exercise on brain and memory in individuals with multiple sclerosis (MS). The article, "Aerobic exercise increases hippocampal volume and improves memory in multiple sclerosis: Preliminary findings," was released as an epub ahead of print on October 4 by Neurocase: The Neural Basis of Cognition. The study was funded by Kessler Foundation.

Hippocampal atrophy seen in MS is linked to the memory deficits that affect approximately 50% of individuals with MS. Despite the prevalence of this disabling symptom, there are no effective pharmacological or behavioral treatments. "Aerobic exercise may be the first effective treatment for MS patients with memory problems," noted Dr. Leavitt, research scientist in Neuropsychology & Neuroscience Research at Kessler Foundation. "Moreover, aerobic exercise has the advantages of being readily available, low cost, self-administered, and lacking in side effects." No beneficial effects were seen with non-aerobic exercise. Dr. Leavitt noted that the positive effects of aerobic exercise were specific to memory; other cognitive functions such as executive functioning and processing speed were unaffected.

The study's participants were two MS patients with memory deficits who were randomized to non-aerobic (stretching) and aerobic (stationary cycling) conditions. Baseline and follow-up measurements were recorded before and after the treatment protocol of 30-minute exercise sessions 3 times per week for 3 months. Data were collected by high-resolution MRI (neuroanatomical volumes), fMRI (functional connectivity), and memory assessment. Aerobic exercise resulted in a 16.5% increase in hippocampal volume, a 53.7% increase in memory, and
'/>"/>

Contact: Carolann Murphy
cmurphy@kesslerfoundation.org
973-324-8382
Kessler Foundation
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Kessler Foundation names Dr. John Whyte recipient of Foundations 2nd Annual DeLisa Award
2. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
3. Kessler Foundation researchers present at first International Congress on Cognition in MS
4. Kessler Foundation scientists present cognitive research findings at MS dual symposium
5. Kessler Foundations A.M. Barrett appointed to National Quality Forum Steering Committee
6. Kessler Foundation and Heldrich Center issue brief on hiring workers with disabilities
7. DeLuca of Kessler Foundation receives research award from American Psychological Association
8. Kessler Foundation presents Brain Injury: From Research to Rebuilding Lives on Sept. 27-28
9. Dr. Chiaravalloti of Kessler Foundation comments on trends in rehabilitation research in MS
10. Kessler Foundation scientist garners best poster award for MS research
11. Kessler Foundation scientists awarded New Jersey grants for brain injury research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Kessler researchers find aerobic exercise benefits memory in persons with multiple sclerosis
(Date:9/2/2015)... ... September 02, 2015 , ... ... investment, announced the two leaders who will deliver keynote presentations at the upcoming ... the Mandarin Oriental Hotel in Boston. , Larry Renfro, CEO of Optum, will ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... Blincyto® (blinatumomab) – in the news recently following a decision by the Centers ... patients – is likely to average approximately $71,000 or roughly 40% of its ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... Officer following the departure of Kristen Dietz, former Chief Operations Officer. Shaun ... the following statement welcoming Mr. Salot: “ Stanley H. Salot Jr , our ...
(Date:9/2/2015)... ... 2015 , ... Good health and a good cause paired up at The ... BCBSNJ) donated $11,000 to the New Jersey Golf Foundation through its Healthy Steps Challenge. ... The Barclays, Horizon BCBSNJ challenged PGA TOUR golfer and NJ native Morgan Hoffmann to ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... at Children's Healthcare of Atlanta to help support childhood cancer research. On ... upcoming WSB Radio Care-A-Thon , which is the fund-raising event DoMyOwnPestControl.com sponsors ...
Breaking Medicine News(10 mins):Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 3Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 2Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 3Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 4Health News:Healtec® Announces Executive Leadership Change 2Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 2Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 3Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2
... a gene that appears to increase a person,s risk ... of the disease. The gene, abbreviated as MTHFD1L, is ... association study. Details are published September 23 in the ... of researchers was led by Margaret A. Pericak-Vance, PhD, ...
... of motorcycle crashes were 1.5 times more likely to ... though many more of the African-American victims were wearing ... new study by Johns Hopkins researchers. Results of ... August issue of the American Journal of Surgery ...
... Steven Reinberg HealthDay Reporter , THURSDAY, Sept. 23 ... use and texting soared in the space of three years, ... alone caused more than 16,000 deaths in car accidents from ... cell phones and texting while driving rose 28 percent in ...
... Cancer Center have discovered a new cell signaling pathway ... when defective, helps promote the formation of several major ... The new pathway, part of a global DNA damage ... are known to cause cancer because, unchecked, they can ...
... Nursing professor, Dr. Diane Doran, was awarded more than ... safety of over 900,000 Canadians who receive health care ... Patient Safety Institute and its partners announced today the ... of Canada,s leading healthcare researchers. The selected research team ...
... a well-crafted football play designed to block the opposing ... constantly executes complex ,plays, or sequences of events to ... Scientists at the University of Rochester Medical Center recently ... the unwanted enlargement of the heart and a well-known ...
Cached Medicine News:Health News:Team of researchers finds possible new genetic risk for Alzheimer's disease 2Health News:Black motorcyclists -- even in helmets -- more likely to die in crashes 2Health News:Texting Taking a Deadly Toll on Roads 2Health News:Texting Taking a Deadly Toll on Roads 3Health News:UCLA cancer researchers discover new signaling pathway that controls cell development and cancer 2Health News:UCLA cancer researchers discover new signaling pathway that controls cell development and cancer 3Health News:$1 million awarded to Bloomberg Faculty of Nursing-led research team 2Health News:Molecular 'playbook' for halting heart failure risk factor uncovered 2
(Date:9/2/2015)... Sept. 2, 2015  ArmaGen, Inc., a privately ... to treat severe neurological disorders, announced today that ... multi-center Phase 1/2a clinical trial of AGT-181 in ... AGT-181 is an investigational enzyme ... I. The most severe form of MPS I, ...
(Date:9/2/2015)... -- Elekta, a global cancer management company, will ... 6:30-8:30 p.m., at Elekta,s North American headquarters in ... will feature Professional BMX athlete, Josh Perry , who ... Leksell Gamma Knife®, Elekta,s radiosurgery system for treating brain disorders. ... diagnosed in Georgia in 2015 and ...
(Date:9/2/2015)... Mass. and TORONTO ... Biotechnology Corporation ( www.generex.com ) (OTCQB: GNBT) ... to implement a buccal cannabis co-development arrangement ... has been formalized. Generex and ... and Technology Licensing Agreement.  Pursuant to the ...
Breaking Medicine Technology:ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 3ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 4Elekta to Host Cancer Survivorship Event at Company's Learning and Innovation Center (LINC) in Atlanta 2Elekta to Host Cancer Survivorship Event at Company's Learning and Innovation Center (LINC) in Atlanta 3Generex Announces Formalization of Buccal Cannabis Co-Development Plan 2Generex Announces Formalization of Buccal Cannabis Co-Development Plan 3
... , , INDIANAPOLIS, Nov. 16 ... Chairman, President and Chief Executive Officer John Lechleiter today presented ... check represents the contributions of Lilly,s U.S. employees and retirees ... funds were raised for the Central Indiana chapter and other ...
... , - Used during coronary angioplasty plus stenting, in ... new reversible blood thinner did not have a significantly ... all-cause mortality, heart attack and need for new procedures ... drug significantly lessened the risk for two pre-specified single ...
Cached Medicine Technology:Lilly Surpasses United Way 2009 Campaign Goal 2Lilly Surpasses United Way 2009 Campaign Goal 3American Heart Association Late-Breaking Clinical Trial Report: New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint, but Did Reduce Death and Stent Thrombosis 2American Heart Association Late-Breaking Clinical Trial Report: New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint, but Did Reduce Death and Stent Thrombosis 3
ASAT (GOT) FS (IFCC mod). For determination of ASAT (GOT) in serum or plasma. For Hitachi 717. Controls: Trulab N and Trulab P....
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 268 U/L at 30C. Two vials, dry powder reagents...
... The DRS 2000, a uniquely intelligent system, ... its space saving, 2-level design. Up to 27 ... to give you the flexibility to tailor your ... lab. Two start stations allow for continuous loading; ...
... latest from the leader in automatic slide ... modern approach to slide staining, ending messy ... blood smears, bone marrow and other body ... Aerospray stainer becomes a superb cytocentrifuge with ...
Medicine Products: